Vaxxilon is developing carbohydrate-based vaccine candidates that should make vaccinations against bacterial infections cheaper in the future. more
License agreement between Max Planck Innovation and Photoswitch Biosciences forms the basis for new platform for identifying and testing novel drug candidates more
Protected STED will improve microscopic imaging of living cells more
The CARE research institute in Munich is set to pursue new approaches in regenerative medicine and drug development more
LDC and Boehringer Ingelheim join forces to discover new compounds more
